S-CEI of Nexium in Paediatric Patients
NCT03562026 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240
Last updated 2021-09-23
Summary
To capture safety and efficacy when Nexium are administered to pediatric patients in clinical practice after launch
Conditions
- Peptic Ulcer, Gastroesophageal Reflux
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Toshihito Nakano · AZKK
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-28
- Primary Completion
- 2020-11-05
- Completion
- 2020-11-05
Countries
- Japan
Study Locations
More Related Trials
-
Phase 1 Pharmacokinetics of Intravenous Nexium in Children
NCT00474019 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in Children
NCT00299845 ·Status: WITHDRAWN ·Phase: PHASE4
-
Nexium Capsules LDA Specific Clinical Experience Investigation
NCT01729182 ·Status: COMPLETED
-
Nexium Capsules Clinical Experience Investigation
NCT01434485 ·Status: COMPLETED
-
Survey Examining the Frequency and Severity of Acid Related Symptoms While Taking Nexium
NCT01130935 ·Status: COMPLETED
-
Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists
NCT01338363 ·Status: COMPLETED
-
Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects
NCT01390714 ·Status: COMPLETED ·Phase: PHASE1
-
Adult Asthmatics and Acid Reflux
NCT00628953 ·Status: COMPLETED ·Phase: PHASE2
-
Chest Pain Pilot Study
NCT00251901 ·Status: COMPLETED ·Phase: PHASE3
-
Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population
NCT00259077 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis
NCT05214768 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease
NCT00847210 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)
NCT01456260 ·Status: COMPLETED ·Phase: PHASE3
-
Reflux Esophagitis Phase III Study (Initial Treatment)
NCT00633932 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)
NCT00687245 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients
NCT00241501 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects
NCT03211143 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)
NCT00242736 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population
NCT00259051 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Gastric Ulcers
NCT00629512 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma
NCT00317044 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects
NCT03444402 ·Status: COMPLETED ·Phase: PHASE1
-
ASTERIX: Low Dose ASA and Nexium
NCT00251966 ·Status: COMPLETED ·Phase: PHASE3
-
Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD
NCT00295685 ·Status: COMPLETED ·Phase: PHASE4
-
Reflux Esophagitis Phase III Study (Maintenance Treatment)
NCT00634114 ·Status: COMPLETED ·Phase: PHASE3